Live feed
Filing
SC 13G
SC 13G0001493152-23-018409·Ayrton Capital LLC
Schedule 13G ownership disclosure
PHARMACYTE BIOTECH INC
Security class unavailable · CUSIP: 71715X203
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-23-018409
- Form type
- SC 13G
- Filer
- Ayrton Capital LLC
- CIK
- CIK 1698148
- Filed
- May 19, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership